中性細胞ゼラチナーゼに関連したリポカリンとフィブリノゲンとアルバミンの比率は,ミクロアルブミヌーリアを有する状細胞疾患患者の腎臓疾患の指標である:ガーナの多センター症例対照研究
PubMedで要約を見る
まとめ
この要約は機械生成です。血清中性細胞ゼラチナーゼ関連リポカリン (sNGAL) とフィブリノゲン対アルブミン比 (FAR) は,状細胞疾患 (SCD) の患者の腎臓疾患の検出に有望である. sNGALは強い独立した早期予測であり,尿素やクレアチニンのような伝統的なマーカーを上回ります.
科学分野
- 腎臓科
- 血液学
- 生物化学
背景
- 中性粒子のゼラチナーゼ関連リポカリン (NGAL) は,認知された腎臓疾患のバイオマーカーである.
- ファイブリノゲンとアルバミン比 (FAR) は,状細胞疾患 (SCD) の腎臓疾患の診断値が不明の炎症マーカーである.
- この研究では,腎臓に問題のある安定状態の成人SCD患者の血清NGAL (sNGAL) とFARの診断用性を調査した.
研究 の 目的
- 大人のSCD患者における腎臓疾患におけるsNGALとFARの診断的役割を調査する.
- SNGALとFARをSCDにおける腎疾患の早期予測マーカーとして評価する.
- 尿素やクレアチニンのような伝統的なマーカーとsNGALの予測値を比較する.
主な方法
- 104人のSCD患者と80人の非SCD対照群を対象とした前向きな症例対照研究.
- 人口統計データと 血液化学指標と 分析用尿サンプルを集めました
- 尿中のアルブミン対クレアチニン比率 (UACR) に基づいて,微アルブミン症と非微アルブミン症のグループに分類された.
主要な成果
- 成人の安定状態のSCD患者では,マイクロアルブミヌリアの罹患率は32. 7%であった.
- マイクロアルブミヌリアのSCD患者では,sNGALとFARの濃度が著しく高かった (p < 0. 001).
- sNGALはUACR (r=0. 45, p=0. 007) と適度な正の相関を示し,強力な早期予測因子 (AUC=0. 854,感度=91. 2%) として浮上した.
- また,FARは有意な予測値 (AUC=0. 630,p=0. 009) を示し,適度な感度と特異性を示した.
結論
- sNGALは,尿素とクレアチニンを上回るSCD患者における腎臓疾患の早期予測因子として独立しています.
- FARは,SCDにおける腎臓疾患の評価のための炎症マーカーとして利用できます.
- これらのマーカーは,SCDにおける腎臓合併症の早期発見と管理のための貴重な洞察を提供します.
関連する概念動画
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

